Skip to content

Examination of safety of supplement and usefulness for antioxidant preliminary examination test

Examination of safety of supplement and usefulness for antioxidant preliminary examination test - Examination of safety of supplements and usefulness of preliminary study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031653
Enrollment
26
Registered
2019-04-01
Start date
2018-03-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

test food: 4 weeks Base food: 4 weeks

Sponsors

IMMUDYNE INC.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: *20 to 80 years old at the time of consent acquisition *Female *Japanese adult women who are not treating diseases that recognize fatigue everyday *Who agreed to participate in the study.

Exclusion criteria

Exclusion criteria: *Those who regularly use health supplements containing antioxidant ingredients such as vitamin C *Persons with a history of treatment of malignant tumor, heart failure, myocardial infarction *Those who are being treated with the following chronic diseases (arrhythmia, liver disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, and neuropsychiatric disorders) *Those who regularly use medicines(including herbal medicine), supplements *Those who regularly use foods for specified health use and functional display foods *One who has allergy to ingredients contained in the test food *Anyone who is willing to pregnant, lactating or intending to become pregnant during the study *Persons who have participated in other clinical trials during the three months prior to the acquisition date of consent *Others who judged that the examination responsible doctor is inappropriate as the subject of this exam

Design outcomes

Primary

MeasureTime frame
*Blood test and urinalysis d-ROM, BAP, 8-OHdG, high-sensitivity CRP *Test point: 0 week, 2 weeks, 4 weeks,

Secondary

MeasureTime frame
*Profile of Mood States 2nd Edition (Japanese version) results *PSQI questionnaire

Countries

Japan

Contacts

Public ContactEiichiro Yagi

IMMUDYNE INC. IMMUDYNE INC. Development Dept.

e-yagi@immudyne.co.jp03-5467-6284

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026